German China India

Downstream Operations

JSR Buys Into Austrian Separations Solutions Manufacturer

| Editor: Dominik Stephan

(Picture: JSR)
Gallery: 1 image
(Picture: JSR)

Japanese JSR expands its biomedical business buy acquiring shares in BIA Separations, an Austrian downstream processing and separations specialist. The company is especially interested in BIA's biomolecule downstream technology, speakers said.

Tokyo/Japan – JSR boost its biomedical business by an investment in BIA Separations. Now the two firms team up for a joint global marketing and sales effort and collaborative. Also R&D activities for downstream purification technologies for the production of vaccine, DNA and antibody based medicines are expected to profit from this development.

This investments opens the doors for JSR to profit from BIA Separation's biomolecule downstream technology, company speakers said. JSR hopes to combine these technologies with its own protein A media for an even aster, more reliable downstream purification process with comparably low cost of ownership.

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 31319810 / Business & Economics)